Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Clinical trial

NCT05275868

1 development in the corpus

NCT05275868

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

SEP 4, 2026 · PHASE 1 TRIAL

Study of MGY825 in Patients With Advanced Non-small Cell Lung Cancer

ClinicalTrials.gov

Phase 1 safety and tolerability study in advanced NSCLC with actual enrollment of 41 participants; no efficacy results reported in this registry record.

PreliminaryMGY825 NCT05275868 Non Small Cell Lung Cancer

Reported

Planned enrollment41

PhasePHASE 1

Primary endpoint duration (safety…28 months

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support